Study uncovers the impact of myocardial infarction on the cardiac conduction system, revealing insights into arrhythmogenesis ...

SAN ANTONIO — For patients with so-called “good-risk” ductal carcinoma in situ (DCIS) who did not have radiation therapy after breast-conserving surgery, adjuvant tamoxifen reduced their ...

Citation: Clinical trial: Adjuvant tamoxifen may reduce recurrence risk for patients with 'good-risk' DCIS who forgo radiation (2024, December 12) retrieved 6 January 2025 from https ...

The estimated 15-year risk of ipsilateral recurrence was 11.4% for patients treated with tamoxifen and 19% for patients who did not receive tamoxifen, a statistically significant difference. When ...

SAN ANTONIO – For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the ...

Broadcaster and DJ, Adele Roberts, is encouraging people to sign up for Cancer Research UK's Race for Life in York.

MONDAY, Dec. 16, 2024 (HealthDay News) -- The established hormone therapy drug tamoxifen can significantly decrease the risk of cancer recurring in women with an early, low-risk form of breast ...

At 15 years, patients who had received immediate surgery had lower rates of distant recurrence and breast cancer death.

Broadcaster and DJ Adele Roberts is urging Scots to kick start the New Year by signing up for Cancer Research UK’s Race for ...

A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target ...

Tamoxifen reduces the rate of breast cancer recurrence by approximately a half. Tamoxifen is metabolized to more active metabolites by enzymes encoded by polymorphic genes, including cytochrome ...